APA (7th ed.) Citation

P, W., R, W., W, Z., Y, Z., D, W., S, Z., . . . X, Z. (2025). Gut microbiota-derived 4-hydroxyphenylacetic acid from resveratrol supplementation prevents obesity through SIRT1 signaling activation. Gut microbes, 17(1), 2446391. https://doi.org/10.1080/19490976.2024.2446391

Chicago Style (17th ed.) Citation

P, Wang, Wang R, Zhao W, Zhao Y, Wang D, Zhao S, Ge Z, Ma Y, and Zhao X. "Gut Microbiota-derived 4-hydroxyphenylacetic Acid from Resveratrol Supplementation Prevents Obesity Through SIRT1 Signaling Activation." Gut Microbes 17, no. 1 (2025): 2446391. https://doi.org/10.1080/19490976.2024.2446391.

MLA (9th ed.) Citation

P, Wang, et al. "Gut Microbiota-derived 4-hydroxyphenylacetic Acid from Resveratrol Supplementation Prevents Obesity Through SIRT1 Signaling Activation." Gut Microbes, vol. 17, no. 1, 2025, p. 2446391, https://doi.org/10.1080/19490976.2024.2446391.